JEFFREY ADELGLASS, M.D., F.A.C.S.
mICHELE rEYNOLDS, m.D., CPI
CLINICAL RESEARCH STUDIES
Dallas | ft. worth TEXAS
currently enrolling subjects for
PAID CLINICAL RESEARCH participation
Due to the unforeseeable risks involved with participating in more than one clinical trial at a time, participation in multiple studies (at RYH and/or other clinical research study centers) is strictly forbidden. Subjects must wait for a specified period after completing one study, before they can begin a new one at RYH.
ARE NOT BREASTFEEDING
OUR RESEARCH VOLUNTEERS:
ARE NOT ALREADY IN A STUDY ELSEWHERE
Every clinical protocol requires that subjects fall within certain age and health ranges to ensure they meet the study's selection criteria, and are physically able to safely complete all participation requirements--but each study is designed differently, and is usually tailored to a very specific population. Having an unhealthy cholesterol level or BMI (Body Mass Index) may disqualify you for one study, but could make you an ideal subject for another. When you screen for a study, be sure to share all requested health history and underlying health issues, whether or not you feel the details are pertinent or serious. This is not only for your safety; it will help us to find the best study for you!
QUALIFIED RESEARCH VOLUNTEERS ARE USUALLY HEALTHY, BUT NOT ALWAYS
Females who are pregnant or are trying to conceive will not be able to participate in a RYH study trial. This is to prevent any exposure to investigational medication or procedures that could potentially harm mother or fetus. If a subject is of child-bearing age and could potentially become pregnant, they must agree to strictly use an approved birth control method while participating in our study. If someone is in one of our studies and discovers that they are pregnant, they should stop all study treatments and immediately notify our office.
ARE NOT PREGNANT OR TRYING TO CONCEIVE
Females who are breastfeeding will not be able to participate in a clinical trial at RYH. This is to prevent all potential harm to nursing children from investigational medication and procedures associated with the study.